Skip to content
Reckitt Benckiser
Search
Join RB’s networks
Facebook
LinkedIn
Twitter
YouTube
Google Plus
Weibo
RB Early Life Blog
Share
Sitemap
HTML version
Text only version
RB worldwide
Global locations
Executive Committee
The Board
RB history
Vision and values
Contact us
Careers & students
Apply now
Why join us?
Jobs for professionals
Graduates & Interns
What it's like at RB
Brand Me
Just for fun
Innovators
Products
People
Awards
Our brands
Powerbrands on the shelf
Products around the home
Commercial break
Search RB Brands A-Z
Category performance
Healthcare Brands Employee Reporting
Suboxone, Subutex & Temgesic adverse events reporting
Our responsibility
betterbusiness
Our Home Our Planet
Trees for Change
Community
Healthier kids Happier homes
Policies & reports
Contact us
Investors & media
Announcements & presentations
The talk about RB
Investor information
Category performance
Corporate governance
Share price information
Shareholder information
Patient organisation donations
Joint working executive summaries
Newsletter registration
Financial support for Healthcare Professionals
Contact us
Home
>
Investors & media
>
Announcements & presentations
>
2011
>
RB appoints new Investor Relations Director
Investors & media
Announcements & presentations
The talk about RB
Investor information
Category performance
Corporate governance
Share price information
Shareholder information
Patient organisation donations
Joint working executive summaries
Newsletter registration
Financial support for Healthcare Professionals
Contact us
Announcements
RB Press Release - 14/07/11
Reckitt Benckiser Group PLC appoints new Investor Relations Director
Reckitt Benckiser Group plc (RB) is pleased to announce the appointment of Richard Joyce as the new RB investor relations director, effective 1 September 2011. In this role Richard will report to Liz Doherty, chief financial officer. To facilitate Richard’s transition into his new role, Tom Corran, who retired from the RB investor relations role in 2008, will be returning to RB as a part-time consultant for the period of a year, effective August 2011.
Richard Joyce is well qualified to take on this new role as he is currently director financial reporting for the Group, a role he has held for 3 years. Previously he was finance director RB Nordic region, and prior to that senior manager internal audit at RB. Richard joined RB in 2002 from PriceWaterhouse Coopers where he worked in both the Sydney, Australia and London, UK offices
ENDS
Investor enquiries, contact:
Jo Speed,
RB +44 (0) 1753 217 800
Press enquiries, contact:
Andraea Dawson-Shepherd,
RB +44 (0)1753 446 447
David Litterick,
Brunswick +44 (0) 207 404 5959
Notes to editors:
Reckitt Benckiser (RB) is a world leader in household, health and personal care. It is a FTSE top 25 company and since 2000 net revenues have doubled and the market cap has quadrupled. Today it is the global No 1 or No 2 in the majority of its fast-growing categories, driven by an exceptional rate of innovation – typically about one third of net revenue comes from innovations launched in the prior 3 years. It has a strong portfolio led by 19 global powerbrands which are: Finish, Lysol, Dettol, Vanish, Woolite, Durex, Calgon, Airwick, Harpic, Bang, Mortein, Veet, Nurofen, Clearasil, Strepsils Gaviscon, Mucinex, Scholl and French’s, and they account for 69% of net revenue.
RB people are at the heart of the company’s success. They have an intense drive for progress and action and a desire to outperform wherever they focus, including in CSR where the company has the most ambitious corporate responsibility programme in the industry through its Carbon 20 initiative.
Headquartered in the United Kingdom, the company employs about 27,000 people worldwide, with operations in over 60 countries and sales in almost 200 countries.
Print this page